4.5 Review

Epigenetic mechanisms of major depression: Targeting neuronal plasticity

Journal

PSYCHIATRY AND CLINICAL NEUROSCIENCES
Volume 72, Issue 4, Pages 212-227

Publisher

WILEY
DOI: 10.1111/pcn.12621

Keywords

depression; DNA methylation; histone acetylation; non-coding RNA; stress

Funding

  1. JSPS [15K09807, 15H04895]
  2. CREST-JST
  3. Takeda Science Foundation
  4. Kanae Foundation for the Promotion of Medical Science
  5. Naito Foundation
  6. Grants-in-Aid for Scientific Research [15H04895, 15K09807, 16K10189] Funding Source: KAKEN

Ask authors/readers for more resources

Major depressive disorder is one of the most common mental illnesses as it affects more than 350 million people globally. Major depressive disorder is etiologically complex and disabling. Genetic factors play a role in the etiology of major depression. However, identical twin studies have shown high rates of discordance, indicating non-genetic mechanisms as well. For instance, stressful life events increase the risk of depression. Environmental stressors also induce stable changes in gene expression within the brain that may lead to maladaptive neuronal plasticity in regions implicated in disease pathogenesis. Epigenetic events alter the chromatin structure and thus modulate expression of genes that play a role in neuronal plasticity, behavioral response to stress, depressive behaviors, and response to antidepressants. Here, we review new information regarding current understanding of epigenetic events that may impact depression. In particular, we discuss the roles of histone acetylation, DNA methylation, and non-coding RNA. These novel mechanisms of action may lead to new therapeutic strategies for treating major depression.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available